Prot #KO-MEN-001: A Phase 1 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Project: Research project

StatusActive
Effective start/end date1/15/201/15/23

Funding

  • ZZZ (Prot #KO-MEN-001)
  • Kura Oncology, Inc. (Prot #KO-MEN-001)